Shots:
- Multi4 Medical received CE mark approval for the Multi4 System, an all-in-one bladder cancer treatment platform enabling treatment during the same outpatient visit without operating room use, anesthesia, or hospitalization
- The Multi4 instrument integrates local anesthesia delivery, tumor resection, automatic tissue extraction for pathology, & cauterization into a single endoscopic device, allowing awake pts to undergo treatment & return home immediately after the procedure
- Clinical validation at Sahlgrenska University Hospital demonstrated successful treatment in 18 pts with the Multi4 system, which was previously approved by the FDA, supporting broader commercialization across the EU
Ref: PRnewswire | Image: Multi4 Medical |Press Release
Related News: Ortho Development Launches Trivicta Cementless Hip Stem for Primary Hip Arthroplasty
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
